Clinically evaluate the effect of Karanja patra ghana vati in comparison with Haridra in early stage of Madhumeha(type 2 Diabetes mellitus)

A randomized clinical study to evaluate Karanja patra (Pongamia pinnata Pierre.) in comparison with Haridra (Curcuma longa Linn.) among patients with early stages of Madhumeha (Type 2 Diabetes mellitus). - nill

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/081871

Enrollment

100

Registered

2025-03-07

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Freshly diagnosed and within one year diagnosed case of Madhumeha 2. Patients between Age group 20 60 years of both sex 3. NIDDM with FBS ranging 120-180mg/dl & PPBS 160-240 mg/dl & HBA1c up to 8%

Exclusion criteria

Exclusion criteria: 1. IDDM 2. Patients with severe cardiac, pulmonary, hepatic disorder and neoplasm. 3. Pregnant & Lactating women 4. HbA1c more than 8%

Design outcomes

Primary

Measure	Time frame
Prabhoota mutrata(Day time) Prabhoota mutrata (Night time) Karapadadaha Mukha Talu Kantha shosha Alasya Atisveda Atinidra Gauravata Timepoint: 1st Assessment- Before Treatment 2nd Assessment- 30th Day 3rd Assessment- 60th Day 4th Assessment-90th Day	—

Secondary

Measure	Time frame
FBS PPBS FUS PPUS HbA1CTimepoint: 1st Assessment- Before Treatment 2nd Assessment- 30th Day 3rd Assessment- 60th Day 4th Assessment-90th Day	—

Countries

India

Contacts

Public ContactDr Prakash L Hegde

sri dharamasthala manjunatheshwara college of Ayurveda and Hospital Hassan

drprakashhegde@yahoo.com9448227115

Outcome results